Epigenetics Market is anticipated to grow at a robust CAGR of 13.6% till 2025 – Agilent Technologies, Active Motif, QIAGEN, Bio-Rad Laboratories, PerkinElmer, New England Biolabs

The study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence is known as epigenetics. A single or multiple change in phenotype without a changing the genotype which results affects the cells that can read the genes. The report would be of an interest to various stakeholders operating in the epigenetics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

DNA methylation Segment is expected to grow the Market for Epigenetics over the Forecast Period for Technology Segment.

According to a new market research study titled ‘Epigenetics Market to 2025 - Global Analysis and Forecasts by Product, Technology, Application and End User. The global epigenetics market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2018-2025. The report highlights the trends prevalent in the global epigenetics market and the factors driving the market along with those that act as deterrents to its growth.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100000971

The report segments the global epigenetics market as follows:

Global epigenetics Market - By Product

Reagents
Kits
Enzymes
Instruments & Consumables

Bioinformatics Tools Global epigenetics Market - By Technology

Histone Modification
DNA Methylation
Others

Global epigenetics Market - By Application
Metabolic Diseases
Oncology
Cardiovascular Diseases
Others

Global Epigenetics Market - By End User
Academics & Research Institutes
Contract Research Organizations
Biotechnology & Pharmaceutical Companies

Global Epigenetics Market - By Geography
North America
U.S.
Canada
Mexico

Europe
U.K.
Germany
France

Asia Pacific (APAC)
Japan
China
India

Middle East & Africa (MEA)
South Africa
UAE
Saudi Arabia

South & Central America (SCAM)
Brazil

Browse Complete Report at https://www.theinsightpartners.com/reports/epigenetics-market

Global epigenetics market, based on technology was segmented histone modification, DNA methylation and other technologies. In 2017, DNA methylation segment held the largest share of the market, by technology. The largest share of the DNA methylation is primarily owing to its ability to develop therapies for diseases including cancer, lupus, muscular dystrophy and various congenital defects and also it helps to prevent conditions that develop during embryonic development such as, abnormal methylation of the X-chromosome and gene imprinting.

The market for epigenetics is expected to grow as declining prices of sequencing, increasing prevalence of cancer, funds & grants provided by government bodies are expected to fuel the market growth during the forecast period. In addition, promising precise treatments by neurogenetics are likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the epigenetics market are Merck KGaA, Thermo Fisher Scientific Inc., ABCAM Plc, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., New England Biolabs (NEB), and Illumina Inc. For instance, in February, 2018, QIAGEN launches epigenetic breast cancer test in Europe. It is the first clinically validated DNA methylation assay that helps predict the response to anthracycline-based chemo by certain high-risk breast cancer patients.

Buy this Report now at https://www.theinsightpartners.com/buy/TIPHE100000971

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: [email protected]

Posted by Sameer Joshi on Wednesday January 09 2019, 2:32 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0